scorecardresearch
Add as a preferred source on Google
Tuesday, November 4, 2025
TopicCancer

Topic: Cancer

Cancer registry covers only 10% of Indians. Call to make it notifiable disease is gathering steam

India ranked 3rd worldwide for new cancer cases in 2020 after China & US, according to GLOBOCAN. Currently, there are 11 notifiable diseases, including TB, cholera & AIDS.

Indian Navy drops plan of third aircraft carrier. Era of ceremonial power projection is over

India's cancer registry barely covers the population. Make it notifiable

36 drugs to treat cancer, rare diseases exempted from basic customs duty in Union Budget 2025

Lakhs of patients are likely to benefit from this move as some of these drugs were exorbitant to procure.

Cancer warning on liquor bottles ‘long overdue’. Even ‘light’, ‘moderate’ drinking poses threat

Even moderate drinking of one-two drinks per day raises cancer risk, say oncologists. New data suggests link of alcohol with cancers of skin, endometrium, ovary, prostate & blood.

Do herbs have a role in cancer care? India’s top cancer research institute leads projects to find out

Question has been topic of heated discussion after Congress leader Navjot Sidhu claimed dietary changes helped his wife beat late-stage cancer. Tata Memorial Centre itself refuted it.

India relied on Western data for cancer care. Now, a platform pulls data from Indian patients

Definite steps are now being taken to understand the profile of cancer in the Indian population. Expect rapid progress in cancer care in India in the coming years.

$7.5mn for testing & 40mn vaccine doses. How India will contribute to Quad Cancer Moonshot scheme

The programme is an extension of the US Cancer Moonshot initiative started in 2016. It aims to strengthen the overall cancer care ecosystem in the Indo-Pacific.  

India’s 1st-ever cancer genomics repository launched, will help tailor treatments for Indian patients

The data portal by Indian Cancer Genome Atlas Foundation currently has data from 50 breast cancer patients & will expand to 500 patients. It'll also include more cancer types soon.

This experimental lung cancer drug outperforms blockbuster medicine Keytruda. But there’s a catch

In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

On Camera

The Kapoors’ love for food is stuff of legends. Netflix gets us a seat at a table

If there is one celebrity who has made talking about food both relatable and entertaining, it is Kareena Kapoor Khan.

Nvidia worth $5 trillion: What does it mean for the market?

The chipmaker at the heart of the AI revolution may be the most influential stock in Wall Street history. Nvidia has been the primary driver of the market’s gains since the start of 2023.

Launch of India’s heaviest comms satellite is a level up for its soaring military ambitions. Here’s how

ISRO’s LMV3 rocket set off the CMS-03 satellite from Sriharikota Sunday. It weighs 4,410 kg, will primarily serve Indian Navy and has a life of at least 15 years.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.